Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.023x

Based on the latest financial reports, Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) has a cash flow conversion efficiency ratio of -0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-17.57 Million ≈ $-2.57 Million USD) by net assets (CN¥756.82 Million ≈ $110.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check Gansu Longshenrongfa Pharmaceutical Indu (300534) strategic asset index to assess the company's strategic physical and investment asset allocation.

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Gansu Longshenrongfa Pharmaceutical Industry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. See Gansu Longshenrongfa Pharmaceutical Indu book value and equity for net asset value and shareholders' equity analysis.

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Elitegroup Computer Systems Co Ltd
TW:2331
0.005x
Brunel International NV
AS:BRNL
0.153x
Jiangsu Gaoke Petrochemical Co
SHE:002778
0.114x
Southern States Bancshares Inc
NASDAQ:SSBK
0.033x
Dredging Corporation of India Limited
NSE:DREDGECORP
0.151x
3D Systems Corporation
NYSE:DDD
-0.061x
Modern Avenue Group Co Ltd
SHE:002656
-0.380x
Fastighets AB Trianon (publ)
ST:TRIAN-B
0.014x

Annual Cash Flow Conversion Efficiency for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Gansu Longshenrongfa Pharmaceutical Indu (300534) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥781.08 Million
≈ $114.30 Million
CN¥-6.54 Million
≈ $-956.57K
-0.008x -103.58%
2024-12-31 CN¥727.93 Million
≈ $106.52 Million
CN¥170.14 Million
≈ $24.90 Million
0.234x +72.29%
2023-12-31 CN¥711.51 Million
≈ $104.12 Million
CN¥96.53 Million
≈ $14.12 Million
0.136x +806.01%
2022-12-31 CN¥763.13 Million
≈ $111.67 Million
CN¥11.43 Million
≈ $1.67 Million
0.015x -78.54%
2021-12-31 CN¥732.84 Million
≈ $107.24 Million
CN¥51.13 Million
≈ $7.48 Million
0.070x +18.56%
2020-12-31 CN¥739.13 Million
≈ $108.16 Million
CN¥43.50 Million
≈ $6.37 Million
0.059x +54.16%
2019-12-31 CN¥738.88 Million
≈ $108.12 Million
CN¥28.21 Million
≈ $4.13 Million
0.038x +168.93%
2018-12-31 CN¥720.83 Million
≈ $105.48 Million
CN¥10.23 Million
≈ $1.50 Million
0.014x +592.28%
2017-12-31 CN¥712.19 Million
≈ $104.22 Million
CN¥-2.05 Million
≈ $-300.53K
-0.003x -115.45%
2016-12-31 CN¥703.74 Million
≈ $102.98 Million
CN¥13.14 Million
≈ $1.92 Million
0.019x -75.26%
2015-12-31 CN¥405.57 Million
≈ $59.35 Million
CN¥30.60 Million
≈ $4.48 Million
0.075x -29.77%
2014-12-31 CN¥363.10 Million
≈ $53.13 Million
CN¥39.01 Million
≈ $5.71 Million
0.107x -4.61%
2013-12-31 CN¥318.92 Million
≈ $46.67 Million
CN¥35.92 Million
≈ $5.26 Million
0.113x -45.79%
2012-12-31 CN¥171.46 Million
≈ $25.09 Million
CN¥35.62 Million
≈ $5.21 Million
0.208x -7.30%
2011-12-31 CN¥45.35 Million
≈ $6.64 Million
CN¥10.16 Million
≈ $1.49 Million
0.224x --

About Gansu Longshenrongfa Pharmaceutical Industry Co Ltd

SHE:300534 China Drug Manufacturers - Specialty & Generic
Market Cap
$360.88 Million
CN¥2.47 Billion CNY
Market Cap Rank
#14156 Global
#4332 in China
Share Price
CN¥8.13
Change (1 day)
-1.22%
52-Week Range
CN¥8.13 - CN¥12.09
All Time High
CN¥29.78
About

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally. It is also involved in the cultivation, processing, and sales of chemical drugs and medicinal herbs, as well as pharmaceutical distribution, testing, and inspection services. The company was founded in 2002… Read more